Arterys company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

arterys.com

Total Raised

$70M

Investors Count

17

Deal Terms

2

Arterys Funding, Arterys Valuation & Arterys Revenue

6 Fundings

Arterys's latest funding round was a Series C for $28M on May 6, 2020.

Arterys's valuation in November 2017 was $82M.

Arterys's latest post-money valuation is from November 2017.

Sign up for a free trial to see Arterys's valuations in December 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/6/2020

Series C

$28M

0

FY undefined

2

11/15/2017

Series B

$99M

$82M

0

FY undefined

10

2/13/2017

Incubator/Accelerator

0

FY undefined

10

3/14/2016

Series A - II

$99M

0

FY undefined

10

12/8/2015

Series A

$99M

$99M

0

FY undefined

10

Date

5/6/2020

11/15/2017

2/13/2017

3/14/2016

12/8/2015

Round

Series C

Series B

Incubator/Accelerator

Series A - II

Series A

Amount

$28M

$99M

$99M

$99M

Investors

Valuation

$82M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

10

10

10

10

Arterys Deal Terms

2 Deal Terms

Arterys's deal structure is available for 2 funding rounds, including their Series B from November 15, 2017.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Arterys Investors

17 Investors

Arterys has 17 investors. Emergent Medical Partners invested in Arterys's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/8/2015

5/6/2020

4
Series A, Series A - II (2016), Series B (2017), Series C (2020)

Venture Capital

California

11/15/2017

5/6/2020

2
Series B, Series C (2020)

Public-Private Partnership

Singapore

11/15/2017

5/6/2020

2
Series B, Series C (2020)

Corporation

California

00/00/0000

00/00/0000

Fosun Capital

Subscribe to see more

Venture Capital

China

00/00/0000

00/00/0000

Benslie Investment Group

Subscribe to see more

Asset/Investment Management

Israel

First funding

12/8/2015

11/15/2017

11/15/2017

00/00/0000

00/00/0000

Last Funding

5/6/2020

5/6/2020

5/6/2020

00/00/0000

00/00/0000

Investor

Fosun Capital

Benslie Investment Group

Rounds

4
Series A, Series A - II (2016), Series B (2017), Series C (2020)
2
Series B, Series C (2020)
2
Series B, Series C (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Public-Private Partnership

Corporation

Venture Capital

Asset/Investment Management

Location

California

Singapore

California

China

Israel

You May Also Like

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Ultromics Logo
Ultromics

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

QUIBIM Logo
QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

Enlitic Logo
Enlitic

Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.

Infervision Logo
Infervision

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Perspectum Logo
Perspectum

Perspectum is a provider of digital technologies that help clinicians provide better care for patients with liver disease. The company's work focuses on the detection and accurate, quantitative measurement of liver, gall bladder, and pacreatic disease.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.